PART I . Overview HCW Biologics Inc. (HCW Biologics or the Company) is a clinical-stage biopharmaceutical company developing transformative fusion immunotherapeutics to support or treat diseases promoted by chronic inflammation. We have created novel compounds that represent a new class of drugs that we believe have the potential to fundamentally change the treatment of autoimmune disorders and other proinflammatory diseases, cancer and senescence-associated dysplasia. Among other things, we hav...
Q2 FY2026 — expected 2026-09-13
| Filed | Period | Accession | Source | Full Text |
|---|---|---|---|---|
| 2026-03-31 | 2025-12-31 | 0001193125-26-134934 | EDGAR | 109K words |
| 2025-03-28 | 2024-12-31 | 0000950170-25-046724 | EDGAR | — |
| 2024-04-01 | 2023-12-31 | 0000950170-24-039384 | EDGAR | — |
| 2023-03-28 | 2022-12-31 | 0000950170-23-010315 | EDGAR | — |
| 2022-03-29 | 2021-12-31 | 0000950170-22-004847 | EDGAR | — |
| Filed | Period | Accession | Source | Full Text |
|---|---|---|---|---|
| 2025-11-14 | 2025-09-30 | 0001193125-25-283238 | EDGAR | 44K words |
| 2025-08-18 | 2025-06-30 | 0000950170-25-109642 | EDGAR | — |
| 2025-05-15 | 2025-03-31 | 0000950170-25-072833 | EDGAR | — |
| 2024-11-14 | 2024-09-30 | 0000950170-24-127198 | EDGAR | — |
| 2024-08-14 | 2024-06-30 | 0000950170-24-097121 | EDGAR | — |
| 2024-05-15 | 2024-03-31 | 0000950170-24-060599 | EDGAR | — |
| 2023-11-14 | 2023-09-30 | 0000950170-23-063359 | EDGAR | — |
| 2023-08-11 | 2023-06-30 | 0000950170-23-041607 | EDGAR | — |
| 2023-05-09 | 2023-03-31 | 0000950170-23-019142 | EDGAR | — |
| 2022-11-07 | 2022-09-30 | 0000950170-22-022697 | EDGAR | — |
| 2022-08-12 | 2022-06-30 | 0000950170-22-017015 | EDGAR | — |
| 2022-05-13 | 2022-03-31 | 0000950170-22-009794 | EDGAR | — |
| Filed | Accession | Source | Full Text |
|---|---|---|---|
| 2026-03-31 | 0001193125-26-134936 | EDGAR | 4K words |
| 2026-03-17 | 0001193125-26-109407 | EDGAR | — |
| 2026-03-02 | 0001193125-26-084291 | EDGAR | — |
| 2026-02-19 | 0001193125-26-059578 | EDGAR | — |
| 2026-02-13 | 0001193125-26-049953 | EDGAR | — |
| 2025-12-31 | 0001193125-25-338026 | EDGAR | — |
| 2025-11-20 | 0001193125-25-289873 | EDGAR | — |
| 2025-11-19 | 0001193125-25-286642 | EDGAR | — |
| 2025-11-18 | 0001193125-25-285325 | EDGAR | — |
| 2025-11-14 | 0001193125-25-283230 | EDGAR | — |
119 total filings indexed. 92 additional filings (S-1, DEF 14A, etc.) View all (JSON) · SEC EDGAR
| CIK | 0001828673 |
| Ticker | HCWB |
| Exchange | Nasdaq |
| SIC | 2834: Pharmaceutical Preparations |
| Incorporated | DE |
| Website | https://www.hcwbiologics.com |
| Listed | 2021-07-20 |
This is the free public profile. For structured JSON with full provenance chain, use the API:
JSON Profile Stock Quote AI Readiness Report